Sign In
Last checked at 
18 May 2023 11:00
IQE plc
Cardiff, UK
18 May 2023
Director/PDMR Shareholding
IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, has been notified that, on 18 May 2023, the following purchases of ordinary shares of 1p each ("Ordinary Shares") were made as part of their participation in IQE's placing, the results of which were announced on 18 May 2023.
Names | Position | No. Ordinary Shares acquired | Resultant holding* | % issued share capital* |
Americo Lemos | Chief Executive Officer | 7,500,000 | 8,470,457 | 0.89% |
Dr Andrew W Nelson | President and Non-Executive Director | 5,000,000 | 45,567,234 | 4.77% |
Phil Smith | Chairman | 100,000 | 140,000 | 0.01% |
Carol Chesney | Non-Executive Director | 50,000 | 90,000 | 0.01% |
Victoria Hull | Non-Executive Director | 50,000 | 281,192 | 0.03% |
*as at admission of the 150,000,000 new Ordinary Shares issued as a result of the Placing, expected to take place on or around 22 May 2023.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. | Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | |||||||||||||||||||
a) | Name | 1. Mr Americo Lemos 2. Dr Andrew W Nelson 3. Phil Smith 4. Carol Chesney 5. Victoria Hull | ||||||||||||||||||
2. | Reason for the notification | |||||||||||||||||||
a) | Position / status | 1. Chief Executive Officer 2. President and Non-Executive Director 3. Chairman 4. Non-Executive Director 5. Non-Executive Director | ||||||||||||||||||
b) | Initial notification / amendment | Initial notification
| ||||||||||||||||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||||||||||||
a) | Name | IQE plc
| ||||||||||||||||||
b) | Legal Entity Identifier | 213800Y33WHD3ESJJP16
| ||||||||||||||||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||||||||||||
a) | Description of the financial instrument | Ordinary shares of 1 pence each in the CompanyGB0009619924
| ||||||||||||||||||
b) | Nature of the transaction | Award of shares
| ||||||||||||||||||
c) | Price(s) and volume(s) |
| ||||||||||||||||||
d) | Aggregated information · Aggregated volume · Aggregated price | n/a - single transactions | ||||||||||||||||||
e) | Date of the transaction(s) | 18 May 2023
| ||||||||||||||||||
f) | Place of the transaction | Off-market
| ||||||||||||||||||
Contacts:
IQE plc
+44 (0) 29 2083 9400
Americo Lemos
Tim Pullen
Amy Barlow
Peel Hunt LLP (Nomad and Joint Broker)
+44 (0) 20 7418 8900
Paul Gillam
Richard Chambers
James Smith
Numis (Joint Broker)
+44 (0) 20 7260 1000
Simon Willis
Hugo Rubenstein
Iqra Amin
Headland Consultancy (Financial PR) + 44 (0) 20 38054822
Andy Rivett-Carnac: +44 (0) 7968 997 365
Chloe Francklin: +44 (0)78 3497 4624
ABOUT IQE
http://iqep.com
IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:
· Smart Connected Devices
· Communications Infrastructure
· Automotive and Industrial
· Aerospace and Security
As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the global market and is enabling customers to innovate at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.
IQE is headquartered in Cardiff UK, with employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.
Follow the stocks
